Lytostx
Lytos Therapeutics develops a vascular-based platform for musculoskeletal pain treatment using proprietary dissolvable microspheres. Their SoluSphere™ technology enables controlled, transient embolization to provide immediate and lasting pain relief through a minimally invasive procedure. The platform is currently in development and slated for future clinical evaluation.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Lytos Therapeutics develops a vascular-based platform for musculoskeletal pain treatment using proprietary dissolvable microspheres. Their SoluSphere™ technology enables controlled, transient embolization to provide immediate and lasting pain relief through a minimally invasive procedure. The platform is currently in development and slated for future clinical evaluation.